EVMN (EVMN) Stock Price & Analysis
EVMN (EVMN) rose 2.25% to USD 12.27 as of September 8, 2026 at 05:02 UTC, according to Nexqual real-time market data.
EVMN last closed at USD 12.27; the session ranged USD 12.02–12.46 on volume of 249,080 shares. Market capitalization is —, with a 52-week range of USD 10.47–33.2 (NYQ). Source: Nexqual, September 8, 2026 at 05:02 UTC.
Key Statistics (as of September 8, 2026 at 05:02 UTC)
| Price | USD 12.27 |
|---|---|
| Change | ▲ 2.25% (up) |
| Previous Close | USD 12.27 |
| Open | USD 12.27 |
| Day Range | USD 12.02 – 12.46 |
| 52-Week Range | USD 10.47 – 33.2 |
| Volume | 249,080 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (EVMN)
Nexqual's technical model rates EVMN "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 05:02 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 41.6 (neutral) |
| vs SMA50 | Below (USD 13.14) |
| MACD | -0.37 (negative) |
From EVMN's Latest SEC 10-K Filing (filed 2026-03-05)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MPLT | MapLight Therapeutics, Inc. | USD 13.77 | ▲ 5.44% |
| ALMS | Alumis Inc. | USD 11.1 | ▲ 7.25% |
| MAZE | Maze Therapeutics, Inc. | USD 26.21 | ▼ 1.91% |
| LBRX | LB Pharmaceuticals Inc | USD 49.34 | ▼ 0.28% |
| SYRE | Spyre Therapeutics, Inc. | USD 88.98 | ▲ 2.22% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:02 UTC. This page is informational and not investment advice.